| Home | Herbal Medicine | Herbs | Symptoms & Ailments | Resort in Beijing | Meet Dr. Chong | Clinical Case Studies | About Us |
|
Red-Rooted Sage
Overview: Dan Shen Root is the dried root of Dan Shen of the Labiate Family. Dan Shen is a common traditional Chinese herb used for invigorating the circulation of blood and reducing stasis. Modern medical research shows that Dan Shen has the effects of resisting bacteria, diminishing inflammation, improving cardiovascular system considerably, avoiding oxygen deficit of cardiac muscle, protecting liver, inhibiting tumour and stabilizing nervous system. Affected by water and heat, its active ingredients decomposed easily in conventional extraction processes. History: Called Red Ginseng in China, it is one of the best-known and best-studied herbs in China. Modern studies confirm that Red Rooted Sage has many benefits: supporting heart function, helping to maintain cholesterol levels already within the normal range, enhancing blood flow, supporting the circulatory system and enhancing the immune system.
Primary Uses:
Parts Used: Root Safety: If you have a history of depression, breast cancer, have pheochromocytoma, ulcers, high blood pressure, or heart or blood vessel disease consult with your physician before using Dan Shen. If you are currently taking medicine or are allergic to any medicine (over the counter or prescription) consult with your physician before using this product. Safety in young children, or pregnant or nursing women is not known. Supporting Research:
1Lo CJ, Lin JG, Kuo JS, Chiang SY, Chen SC, Liao ET, Hsieh CL., Institute of Chinese Medical Science, China Medical College, Taichung, Taiwan, ROC., [Effect of salvia miltiorrhiza bunge on cerebral infarct in ischemia-reperfusion injured rats.], Am J Chin Med. 2003;31(2):191-200. 2Xia Z, Gu J, Ansley DM, Xia F, Yu J., Department of Anesthesiology, Affiliated Renmin Hospital, Wuhan University, PR China., [Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease.], J Thorac Cardiovasc Surg. 2003 Nov;126(5):1404-10. |
|
